News related to Fiorinal with Codeine (Codeine / Butalbital / Caffeine / Aspirin) and/or conditions it is approved for
September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache And Dual Energy X-Ray Imaging
Source: Eye Health / Blindness News From Medical News Today [2008.09.04]
One aspect of aging that's usually fixable is cloudy vision due to cataracts. In an otherwise healthy eye, cataract removal results in improved vision 95 percent of the time, according to the September issue of Mayo Clinic Health Letter. Cataracts are common. By age 65, about half of all Americans have developed some degree of lens clouding due to cataracts.
Acupuncture may ease chronic headaches (Reuters)
Source: Y! Health Alternative Medicine News [2008.08.26]
Reuters - Acupuncture may bring some
added pain relief to people with chronic headaches, a new study
suggests.
FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
Source: Bipolar News From Medical News Today [2008.08.01]
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," said Gary J.
Oxygen Therapy Might Ease Pain Of Migraine, Cluster Headaches
Source: Headache / Migraine News From Medical News Today [2008.07.16]
Two types of oxygen therapy could offer some relief to adults who suffer from disabling migraine and cluster headaches, according to a new research review from Australia. Migraine headaches are severely painful and usually occur with other symptoms such as nausea, vomiting and painful sensitivity to light. Cluster headaches cause sharp, burning pain on one side of the head.
Health Tip: Help Prevent Headaches
Source: MedicineNet Migraine Headache Specialty [2008.07.03]
Title: Health Tip: Help Prevent Headaches
Category: Health News
Created: 7/3/2008 2:00:00 AM
Last Editorial Review: 7/3/2008
MAP Pharmaceuticals Reports Positive Pharmacological Response Data For Migraine Product Candidate At The American Headache Society Annual Meeting
Source: Headache / Migraine News From Medical News Today [2008.06.29]
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) presented data from an in-vitro study evaluating receptor pharmacology of MAP0004, orally inhaled dihydroergotamine (DHE) for the potential treatment of migraine, compared to intravenous (IV) DHE. The study results were among six posters relating to the MAP0004 program that the Company presented at the American Headache Society 50th Annual Scientific Meeting in Boston, MA.
Knowledge And Understanding Ease Headache Frustrations
Source: Headache / Migraine News From Medical News Today [2008.06.27]
Headache frustrations are set to ease, thanks to a new range of patient leaflets. Produced by Lifting The Burden, the World Health Organization's Global Campaign to Reduce the Burden of Headache Worldwide, they will help sufferers understand and manage their headache more effectively. Almost all of us will have had a headache, but for many people it is more than just an irritant.
Headache Specialists Convene In Boston For 50th Annual American Headache Society Meeting
Source: Headache / Migraine News From Medical News Today [2008.06.27]
Headache specialists meet in Boston for the 50th annual meeting of the American Headache Society. Learn more about headache and face pain developments of the last 50 years -- including the top five advances in headaches -- and what researchers envision for the future.
Alexza Pharmaceuticals To Present AZ-104 Phase 2a Clinical Data At The American Headache Society Annual Scientific Meeting
Source: Headache / Migraine News From Medical News Today [2008.06.24]
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine headache at the 50th Annual Scientific Meeting of the American Headache Society, which being held at the Marriott Boston Copley Place in Boston, MA.
Headache
Source: MedicineNet Legionnaire Disease and Pontiac Fever Specialty [2007.03.23]
Title: Headache
Category: Diseases and Conditions
Created: 5/31/2002
Last Editorial Review: 3/23/2007
Spinal Headaches
Source: MedicineNet Meningococcemia Specialty [2005.02.04]
Title: Spinal Headaches
Category: Diseases and Conditions
Created: 2/4/2005 4:54:00 PM
Last Editorial Review: 2/4/2005 4:53:50 PM
Cluster Headaches
Source: MedicineNet zolmitriptan Specialty [2005.02.04]
Title: Cluster Headaches
Category: Diseases and Conditions
Created: 2/4/2005 4:36:00 PM
Last Editorial Review: 2/4/2005 4:36:23 PM
New Tool Gives A Heads-Up For Athletes After A Concussion
Source: Sports Medicine / Fitness News From Medical News Today [2008.08.30]
For 19-year-old Karlee Carbert, rugby isn't just a sport, it's a passion. But the rough and tumble game can be physically demanding, as Carbert reveals "some games you can hit your head as many as five times." Carbert has suffered three concussions in her career but after the first two her response was the same, "usually you hit your head, get a headache and once the headache is gone you go back.
Army Personnel Show Increased Risk For Migraine - Condition Underdiagnosed, Mistreated
Source: Headache / Migraine News From Medical News Today [2008.08.29]
Two new studies show that migraine headaches are very common among U.S. military personnel, yet the condition is frequently underdiagnosed. The studies, appearing in Headache, the peer-reviewed journal of the American Headache Society, examine the incidence among soldiers within 10 days of returning from a 1-year combat tour in Iraq , as well as U.S. Army officer trainees. The U.S.
YorkTest Laboratories Reveal The UK's Top Ten Intolerant Foods - Two Out Of Three Brits Are Intolerant To Cow's Milk And Eggs
Source: Allergy News From Medical News Today [2008.08.05]
Statistics out today from the leading food intolerance expert, YorkTest, show that nine out of the ten of the UK's most intolerable foods are commonly found on our breakfast table - proving it really is the most important meal of the day. If you wondered why you were going to work on a headache, to school with a stomach ache or to a lecture with lethargy, a breakfast of toast, egg or cereal could be the reason why.
Canadian Scientists Report On Pain Research At NIDCR's 60th Anniversary Symposium
Source: Body Aches News From Medical News Today [2008.07.03]
Nearly everyone has experienced the acute, short-lived pain that occurs after a mild injury, but recent surveys reveal that more than 20% of the population has a chronic pain condition (i.e., pain that has lasted for 3 months or more) and for which treatment is often not very effective (e.g., low back pain, fibromyalgia, migraine headaches). Acute and chronic pain conditions have huge socio-economic costs.
Migraine Mutations Reveal Clues To Biological Basis Of Disorder
Source: Headache / Migraine News From Medical News Today [2008.07.01]
Fifteen percent to 20 percent of people worldwide suffer from migraines excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder. In the Proceedings of the National Academy of Sciences, Alfred George Jr., M.D.
Zogenix Announces Clinical Study Results For Sumatriptan DosePro™, A Novel Migraine Treatment
Source: Headache / Migraine News From Medical News Today [2008.06.30]
Zogenix, Inc. ("Zogenix"), a private, specialty pharmaceutical company, announced that it will present successful results from two clinical studies of sumatriptan DosePro, a product in development for treatment of acute migraine and cluster headache, at the 50th Annual American Headache Society Meeting in Boston, Massachusetts.
Data On Highly Effective Migraine Treatment Presented By OptiNose
Source: Headache / Migraine News From Medical News Today [2008.06.30]
OptiNose has announced that it presented important new data demonstrating the superior performance of its novel nasal drug delivery device with sumatriptan for the treatment of migraines. The Phase II results indicate that the drug-device combination achieves migraine relief as quickly and efficiently as injections without the discomfort, inconvenience and risk of needle-stick injuries. OptiNose presented the data at the Annual Scientific Meeting of the American Headache Society in Boston.
Migraine "Gun" Zaps Pain With The Touch Of Button - FDA Close To Approving Device That Uses Magnetic Bursts To Stop Pain
Source: Headache / Migraine News From Medical News Today [2008.06.28]
There are some 30 million Americans who suffer from migraine headaches.* Researchers at Ohio State University Medical Center have unveiled a new device that can control the pain of migraine headaches with no drugs, no injections, and no side effects. In fact this device is as easy as touching a button. After nearly eight years of development the migraine zapper could be on the market in a matter of months.
Medtronic Announces First Clinical Data On Occipital Nerve Stimulation For Chronic Migraine
Source: Headache / Migraine News From Medical News Today [2008.06.27]
Medtronic, Inc. (NYSE: MDT) announced that data from a multicenter, prospective, randomized, singleblinded, Controlled investigational study using its neurostimulation system to stimulate the occipital nerves as a potential approach to treating medically refractory chronic migraines will be presented during a late-breaking session at the annual scientific meeting of the American Headache Society (AHS) tomorrow in Boston.
Portable Device Effective In Zapping Away Migraine Pain
Source: Headache / Migraine News From Medical News Today [2008.06.27]
A novel electronic device designed to "zap" away migraine pain before it starts has proven to be the next form of relief for those suffering from the debilitating disease, according to a study conducted at The Ohio State University Medical Center. Results of the study, presented TODAY (6/27) at the annual American Headache Society meeting in Boston, found that the experimental device is safe and effective in eliminating headaches when administered during the onset of the migraine.
|
